702 related articles for article (PubMed ID: 26234646)
41. Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats.
Bernátová I; Pechánová O; Simko F
Physiol Res; 1996; 45(4):311-6. PubMed ID: 9085355
[TBL] [Abstract][Full Text] [Related]
42. Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats.
Zhang CX; Pan SN; Meng RS; Peng CQ; Xiong ZJ; Chen BL; Chen GQ; Yao FJ; Chen YL; Ma YD; Dong YG
Clin Exp Pharmacol Physiol; 2011 Jan; 38(1):55-62. PubMed ID: 21083698
[TBL] [Abstract][Full Text] [Related]
43. Antihypertensive Effects of Roselle-Olive Combination in L-NAME-Induced Hypertensive Rats.
Abdel-Rahman RF; Hessin AF; Abdelbaset M; Ogaly HA; Abd-Elsalam RM; Hassan SM
Oxid Med Cell Longev; 2017; 2017():9460653. PubMed ID: 29201276
[TBL] [Abstract][Full Text] [Related]
44. Sinapic acid prevents hypertension and cardiovascular remodeling in pharmacological model of nitric oxide inhibited rats.
Silambarasan T; Manivannan J; Krishna Priya M; Suganya N; Chatterjee S; Raja B
PLoS One; 2014; 9(12):e115682. PubMed ID: 25531679
[TBL] [Abstract][Full Text] [Related]
45. Mamao Pomace Extract Alleviates Hypertension and Oxidative Stress in Nitric Oxide Deficient Rats.
Kukongviriyapan U; Kukongviriyapan V; Pannangpetch P; Donpunha W; Sripui J; Sae-Eaw A; Boonla O
Nutrients; 2015 Jul; 7(8):6179-94. PubMed ID: 26225998
[TBL] [Abstract][Full Text] [Related]
46. Antioxidant and vasorelaxant effects of aqueous extract of large cardamom in L-NAME induced hypertensive rats.
Kanthlal SK; Joseph J; Paul B; M V; P UD
Clin Exp Hypertens; 2020 Oct; 42(7):581-589. PubMed ID: 32202168
[TBL] [Abstract][Full Text] [Related]
47. Tangeretin ameliorates erectile and testicular dysfunction in a rat model of hypertension.
Chiangsaen P; Maneesai P; Kukongviriyapan U; Tong-Un T; Ishida W; Prachaney P; Pakdeechote P
Reprod Toxicol; 2020 Sep; 96():1-10. PubMed ID: 32479886
[TBL] [Abstract][Full Text] [Related]
48. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
[TBL] [Abstract][Full Text] [Related]
49. Soy protein hydrolysate ameliorates cardiovascular remodeling in rats with L-NAME-induced hypertension.
Yang HY; Yang SC; Chen ST; Chen JR
J Nutr Biochem; 2008 Dec; 19(12):833-9. PubMed ID: 18479899
[TBL] [Abstract][Full Text] [Related]
50. Chronic inhibition of nitric oxide synthase induces hypertension and cardiomyocyte mitochondrial and myocardial collagen remodelling in the absence of hypertrophy.
Rossi MA; Ramos SG; Prado CM
J Hypertens; 2003 May; 21(5):993-1001. PubMed ID: 12714875
[TBL] [Abstract][Full Text] [Related]
51. Angiotensin II type 1 receptor antagonism improves endothelial vasodilator function in L-NAME-induced hypertensive rats by a kinin-dependent mechanism.
De Gennaro Colonna V; Fioretti S; Rigamonti A; Bonomo S; Manfredi B; Muller EE; Berti F; Rossoni G
J Hypertens; 2006 Jan; 24(1):95-102. PubMed ID: 16331106
[TBL] [Abstract][Full Text] [Related]
52. Effects of Cudrania tricuspidata water extract on blood pressure and renal functions in NO-dependent hypertension.
Kang DG; Hur TY; Lee GM; Oh H; Kwon TO; Sohn EJ; Lee HS
Life Sci; 2002 Apr; 70(22):2599-609. PubMed ID: 12269387
[TBL] [Abstract][Full Text] [Related]
53. Sildenafil augments the beneficial hemodynamic and histopathological effects of amlodipine in nitric oxide-deficient hypertensive rats: role of nitric oxide-cyclic GMP pathway.
Aboutabl ME; Raafat M; Maklad YA; Kenawy SA; El Din AG
Pharmacol Res; 2008 Jun; 57(6):456-63. PubMed ID: 18572415
[TBL] [Abstract][Full Text] [Related]
54. N-acetylcysteine treatment normalizes serum tumor necrosis factor-alpha level and hinders the progression of cardiac injury in hypertensive rats.
Bourraindeloup M; Adamy C; Candiani G; Cailleret M; Bourin MC; Badoual T; Su JB; Adubeiro S; Roudot-Thoraval F; Dubois-Rande JL; Hittinger L; Pecker F
Circulation; 2004 Oct; 110(14):2003-9. PubMed ID: 15451797
[TBL] [Abstract][Full Text] [Related]
55. Effect of simvastatin on remodeling of the left ventricle and aorta in L-NAME-induced hypertension.
Simko F; Matuskova J; Luptak I; Krajcirovicova K; Kucharska J; Gvozdjakova A; Babal P; Pechanova O
Life Sci; 2004 Jan; 74(10):1211-24. PubMed ID: 14697405
[TBL] [Abstract][Full Text] [Related]
56. Regression of L-NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor.
Paulis L; Zicha J; Kunes J; Hojna S; Behuliak M; Celec P; Kojsova S; Pechanova O; Simko F
Hypertens Res; 2008 Apr; 31(4):793-803. PubMed ID: 18633192
[TBL] [Abstract][Full Text] [Related]
57. Nicorandil but not ISDN upregulates endothelial nitric oxide synthase expression, preventing left ventricular remodeling and degradation of cardiac function in Dahl salt-sensitive hypertensive rats with congestive heart failure.
Horinaka S; Kobayashi N; Yagi H; Mori Y; Matsuoka H
J Cardiovasc Pharmacol; 2006 May; 47(5):629-35. PubMed ID: 16775500
[TBL] [Abstract][Full Text] [Related]
58. Role of nitric oxide in the expression of hepatic vascular stress genes in response to sepsis.
Eum HA; Park SW; Lee SM
Nitric Oxide; 2007; 17(3-4):126-33. PubMed ID: 17889572
[TBL] [Abstract][Full Text] [Related]
59. Atorvastatin enhanced nitric oxide release and reduced blood pressure, nitroxidative stress and rantes levels in hypertensive rats with diabetes.
Mason RP; Corbalan JJ; Jacob RF; Dawoud H; Malinski T
J Physiol Pharmacol; 2015 Feb; 66(1):65-72. PubMed ID: 25716966
[TBL] [Abstract][Full Text] [Related]
60. Sesamin enhances nitric oxide bioactivity in aortas of spontaneously hypertensive rats.
Kong X; Li W; Guo LQ; Zhang JX; Chen XP; Liu WY; Yang JR
Ther Adv Cardiovasc Dis; 2015 Oct; 9(5):314-24. PubMed ID: 26037786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
